Researchers based in Africa have more comprehensive understanding of malaria: MIM

NewsGuard 100/100 Score

Organisations supporting medical research in Africa, for example research on malaria, cannot assume that scientific results are independent of time and space. Instead the results reflect the interplay between the research environment, researchers and the study object. This is the result of a dissertation in Theory of Science from the University of Gothenburg, Sweden. 

Gunilla Priebe has studied the international research alliance the Multilateral Initiative on Malaria (MIM), which advocates for malaria research in general and the strengthening of research environments in Africa. Malaria research has historically been controlled by interests located in areas outside Africa. This has led to a huge gap in knowledge in relation to the malaria problems that dominate everyday life in those areas where people are most affected by the disease. Better opportunities for researchers on site. According to MIM, researchers based in Africa have a more comprehensive understanding of malaria and its effects on the population.

In addition, a locally based researcher is often more motivated to solve problems that are of considerable significance for the majority of malaria patients. "Proximity to the environment where the social, political, economic as well as the biological dynamics related to malaria are evident provides the researcher with better opportunities to formulate relevant research questions. If the research is based in Africa it increases the chances of the results being of some practical use," says Gunilla Priebe.  Africanisation brings fresh approachGunilla Priebe's analysis is framed by the concept of "Africanisation", which in relation to scientific knowledge production entails two integrated themes: the meaning of time and location with regard to researchers' ability to represent a study object correctly and in a relevant manner, and partly the impact of remnants of colonialism on the production of scientific knowledge. 

According to Gunilla Priebe, the study of MIM shows that Africanisation of malaria research means investments in infrastructure, education and improved forms for research cooperation. In such a case, Africanisation will also lead to innovative approaches when it comes to research methods and arguments, as well as enhanced influence from both patient and researcher groups that have in the past been marginalised within malaria research. Definition of researcher's roleBased on the conclusions drawn from Theory of science study of MIM, Gunilla Priebe's recommendation to research organisations, such as philanthropic foundations and national aid and research bodies, is to evaluate the role of research for development in the same way as other "foreign" initiated development cooperation. "Naturally more money for research into malaria is welcomed, but if the organisations that support research in and about Africa don't intend to reproduce colonial methods, then these cannot work on the basis of utopian ideals of scientific autonomy.

They must also take such issues as the right to co-ownership at each stage of knowledge production into consideration. Neither can they focus solely on financial support or the content and organisation of the research; they must also engage with the political and social effects of research and research support," says Gunilla Priebe.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows